stock price decline

Kirby McInerney LLP filed securities fraud lawsuit against Kyndryl Holdings for alleged financial misstatements and inadequate internal controls. Stock plummeted 55% after SEC scrutiny.

NuScale Power faces class action lawsuit alleging false statements about partner ENTRA1's qualifications. Stock declined 12% after disclosing $495M payment and $532M quarterly loss.

Hub Group restated 2025 financials after discovering material accounting errors in transportation costs and payables. Stock fell 18.3%, triggering shareholder lawsuits over disclosure adequacy.

Law firm investigates Gemini Space Station after three senior executives abruptly resigned, causing stock to plummet 12.83%. Seeking shareholders for potential class action lawsuit.

Law firm investigates GRAIL for potential securities violations after cancer trial failure triggered stock decline. Examining whether company adequately disclosed trial risks.

Law firm investigates KDDI after delayed earnings report. Stock dropped 11.44% following announcement of internal review postponement.

Law firm launches securities probe into Danone after toxin found in infant formula triggers product recalls and stock declines of over 10%.

ICON's Audit Committee investigates revenue recognition control deficiencies from 2023-2025. Stock plunged 40% after disclosure; company delayed financials and withdrew 2025 guidance.

Class action lawsuit alleges uniQure withheld FDA study design concerns from investors, causing 49% stock decline after disclosure in November 2025.

Agilon Health faces securities lawsuit over allegedly false 2025 guidance. Stock fell 51.6% after CEO termination and guidance suspension on August 4.

Klarna faces securities class action over allegedly misleading IPO statements about loss reserves. Lead plaintiff deadline set for February 20, 2026.

Vistagen faces class action lawsuit for securities fraud after its Phase 3 trial failed, causing stock to plummet 80%. Investors allege misleading statements about trial progress.

BellRing Brands faces securities lawsuit alleging false sales disclosures. Stock fell 51.6% after company allegedly misattributed inventory hoarding to market demand.

Class action filed against Ramaco Resources (METC) alleging misrepresentations about Brook Mine operations. Stock fell 9.6%; investors from July-October 2025 eligible to join lawsuit.

Kyndryl faces securities class action after disclosing internal control weaknesses, CFO/General Counsel departures, and 55% stock decline. Lead plaintiff deadline is April 13, 2026.

Ultragenyx faces securities lawsuit after failing to disclose setrusumab trial failure, causing 42% stock drop. Investors claim company withheld material information before December announcement.

uniQure faces securities lawsuit over failing to disclose that FDA rejected its gene therapy candidate AMT-130, causing stock to plunge 49%. Lead plaintiff deadline set for April 13, 2026.

BellRing Brands faces securities lawsuit for failing to disclose material information about business challenges between November 2024 and August 2025, leading to significant stock declines.

Ardent Health faces securities lawsuit over undisclosed financial declines. Lead plaintiff applications due March 9, 2026 for investors with losses exceeding $100,000.

Varonis Systems faces class action lawsuit after stock plunged 48.67% on October 29 following missed revenue projections and weak customer conversions disclosure.